Press Releases
In this section we publish press releases from our corporate members and other companies wishing to publicise their recent advances. Corporate membership gives our professional members many benefits and is designed to help promote biotech companies and products. If you wish to list your press release on this page then please contact us for rates.
Clinical Data Published for a Phase I AADC-deficiency Trial Using a Gene Therapy Manufactured by Florida Biologix
- Details
- Category: Press Releases
- Published on Thursday, 17 May 2012 06:35
- Written by Chris Aytug
- Hits: 9
ALACHUA, FL May 16, 2012 - Florida Biologix®, a full-service biopharmaceutical development and contract manufacturing organization, provided cGMP manufacturing services to National Taiwan University Hospital under a contract signed in March 2008. Florida Biologix produced, purified, and tested a clinical batch of their novel gene therapy for a Phase I clinical trial of a rare genetic disease – AADC deficiency. The trial was led by Dr. Paul Wuh-Liang Hwu. Results of the clinical trial were published in the May 16th issue of Science Translational Medicine.
More Articles...
- cGMP CMO Florida Biologix® Announces EU Compliant Aseptic Fill-Finish and Facility Enhancements for Biopharmaceutical Drug Products
- Florida Biologix® Announces Manufacturing Agreement with Altor BioScience
- Synpromics: Scotland’s Latest Biotech Company
- Use of Pregnancy-Associated Genetic Signatures for Diagnosis and Treatment of Breast Cancer
Menu
User Login
Follow Us On
